J&J recalled 33,000 bottles of its baby powder earlier in the month after the FDA said it found trace amounts of asbestos in the product. Shortly after the recall, Walmart, CVS Health and Rite Aid pulled the baby powder off their shelves.
The company said two third-party labs ran 15 new tests on the baby powder and found no sign of asbestos. Its shares jumped 4 percent in after-hours trading after the announcement, and Jared Holz, a healthcare strategist at Jeffires, told CNBC he expects $10 billion to $15 billion to be added back to the company’s market cap.
J&J still faces thousands of lawsuits alleging its talc-based products, such as its baby powder, cause cancer.
More articles on supply chain:
FDA warns of critical medical device shortages
UPS expanding healthcare warehouse, distribution network
FDA warns of blood leak risk with endografts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
